About

Who We Are

We are senior-level professionals with the expertise required to serve our customers’ needs fully and efficiently. Our clients range from the largest pharmaceutical and medical device companies, through medium sized companies, to start-ups, as well as State and Federal government entities.


Frederick Cahn, Ph.D., CEO

Dr. Cahn has over 30 years experience in scientific research, invention, technology and product development, clinical studies, regulatory negotiations, reimbursement and marketing. Current chairman of the ASTM comittee that deals standards for tissue engineered medical products (F04.41), Dr. Cahn has served on government peer review committees, university industrial advisory boards, and medical product standardization organizations.

Emily Galati, B.A., COOsend a message to Emily

Ms. Galati has over 18 years experience in business development, market research, competitive analysis, product development, product launches, reimbursement, and government relations. She has worked successfully at the local and national levels with senior policy personnel at privation government third party payer organizations, including the Centers for Medicare and Medicaid Services, to ensure appropriate payment for medical devices and pharmaceuticals.

James N. Arvesen, Ph.D., Director of Statisticssend a message to James

Dr. Arvesen has over 30 years of quantitative marketing and bio-statistics experience. Dr. Arvesen directed market research and planning and clinical statistics at Pfizer and was a founder and the president of Amixis Inc., a successful marketing and biostatistics consulting firm. He is an authority and leader in applying advanced statistical methods to competitive intelligence for maximizing the impact of marketing and sales force resources, as well an expert in clinical statistics.

Reimbursement

Reimbursement is critical to market success for products that are administered in hospitals or clinics. BMS advises planning for reimbursement at every stage of product development. Reimbursement issues, such as whether new or existing medical codes are appropriate, affect regulatory choices in product claims and labeling and (for devices) whether to prepare 510(k) vs.PMA applications.

Economics

Clinical studies are the key to achieving acceptance of new technologies and medical treatments not only for regulatory authorities, but also for reimbursement coverage, formulary acceptance, and physician utilization. Success in clinical studies can be achieved only by excellence and attention to detail in clinical protocols and statistical plans.

Marketing

Managed care has transformed the pharmaceutical and medical device marketplace. Physicians, hospital administrators, and managed care medical directors need relevant, credible information, and your marketing program needs to deliver this information effectively. Accurate competitive intelligence that is timely and segmented can be the key to maximizing market penetration while minimizing sales force costs.